This MedLibrary.org supplementary page on BMPR2 is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
|
BMPR2
|
|
| Identifiers | |
| Symbol | BMPR2 |
| Alt. Symbols | PPH1 |
| Entrez | 659 |
| HUGO | 1078 |
| OMIM | 600799 |
| Other data | |
| Locus | Chr. 2 q33-q34 |
Bone morphogenetic protein receptor type II or BMPR2 is a serine/threonine receptor kinase. It binds Bone morphogenetic proteins, members of the TGF beta superfamily of ligands. BMPs are involved in host of cellular functions including osteogenesis, cell growth and cell differentiation. Signaling in the BMP pathway begins with the binding of a BMP to the the type II receptor. This causes the recruitment of a BMP type I receptor, which it phosphorylates. The Type I receptor phosphorylates an R-SMAD a transcriptional regulator.
Function
Unlike the TGFβ type II receptor, which has a high affinity for TGF-β1, BMPR2 does not have a high affinity for BMP-2, BMP-7 and BMP-4, unless it is co-expressed with a type I BMP receptor1. In TGF beta signaling all of the receptors exist in homodimers before ligand binding. In the case of BMP receptors only a small fraction of the receptors exist in homomeric forms before ligand binding. Once a ligand has bound to a receptor, the amount of homomeric receptor oligomers increase, suggesting that the equilibrium shifts towards the homodimeric form1. The low affinity for ligands suggests that BMPR2 may differ in the from other type II TGF beta receptors in that the ligand may bind the type I receptor first2.
References
- ^ a b Gilboa, L; Nohe A, Geissendorfer T, Sebald W, Henis YI, Knaus P. (March 2000). "Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors". Mol Biol Cell. 11 (3), http://www.molbiolcell.org/cgi/content/full/11/3/1023. Retrieved on 3 July 2006.
- ^ Kirsch, T; Nickel J, Sebald W. (July 2000). "BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II". EMBO J. 19 (13). PMID 10880444, http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=10880444. Retrieved on 3 July 2006.
|
||||||||||||||||||||
|
||||||||||||||||||||
BMPR2 functions (among others) to inhibit the proliferation of vascular smooth muscle so when this gene is altered vascular smooth muscle proliferates and leads to pulmonary hypertension which among other things can lead to cor pulmonale. (robbins and cotran for usmle step 1).
Wikipedia content modification information:
- This page was last modified on 24 October 2008, at 00:06.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "BMPR2".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.